A carregar...

CDK4/6 inhibition in luminal breast cancer

Endocrine therapy represents the basis for the treatment of estrogen receptor-positive breast cancer, but several tumors harbor intrinsic resistance and acquired resistance to endocrine therapy is inevitable in metastatic disease. Combination strategies of endocrine therapy with targeted agents are...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Memo
Main Authors: Gampenrieder, Simon Peter, Rinnerthaler, Gabriel, Greil, Richard
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Vienna 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4923084/
https://ncbi.nlm.nih.gov/pubmed/27429659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-016-0268-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!